Email ID
Password
Scrip   
EU's CHMP negative on Antigenics' therapeutic cancer vaccine Oncophage
23 November 2009
Malini Guha

The EU's CHMP has turned down what could have been the first therapeutic cancer vaccine approved in the EU, Antigenics' novel therapy Oncophage (HSPPC-96; vitespen), as an adjuvant treatment for renal cell carcinoma (RCC). The agency said that Oncophage did not demonstrate its effectiveness in prolonging...



Please Login to read the full article.
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36